Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer

NCT01251536 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Dose escalation of cetuximab
DRUG: Standard first line treatment with cetuximab + Folfiri

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]